Intravenous Vitamin C prolongs liver cancer patients’ survival

IV vitamin C even at 2gms for at least 4 infusions, not only increased the Disease Free survival by an average of 7 months, it showed to actually kill cancer stem cells.

from WordPress http://ift.tt/2GcPdNa
via IFTTT

Intravenous Vitamin C prolongs liver cancer patients’ survival

IV vitamin C even at 2gms for at least 4 infusions, not only increased the Disease Free survival by an average of 7 months, it showed to actually kill cancer stem cells.

Are you sure you want to do alternative therapies?

Questions you need to ask and facts you need to know before deciding to do alternative cancer treatments.

from WordPress http://ift.tt/2BlOgyq
via IFTTT

Are you sure you want to do alternative therapies?

Questions you need to ask and facts you need to know before deciding to do alternative cancer treatments.

Are you sure you want to do alternative therapies?

Questions you need to ask and facts you need to know before deciding to do alternative cancer treatments.

via WordPress http://ift.tt/2BlOgyq

Circulating Tumor DNA bases for cancer diagnosis

A single blood test can detect 8 types of cancer, CANCERSEEK is still in its infant stages

Circulating Tumor DNA bases for cancer diagnosis

A single blood test can detect 8 types of cancer, CANCERSEEK is still in its infant stages

via WordPress http://ift.tt/2FVVXyX

Circulating Tumor DNA bases for cancer diagnosis

A single blood test can detect 8 types of cancer, CANCERSEEK is still in its infant stages

from WordPress http://ift.tt/2FVVXyX
via IFTTT

BRCA mutations are not a predictor of higher mortality

Patients with BRCA mutations are 45 -90% more likely to develop breast or ovarian cancer, but mortality is about the same as patients with non mutated BRCA gene.

BRCA mutations are not a predictor of higher mortality

Patients with BRCA mutations are 45 -90% more likely to develop breast or ovarian cancer, but mortality is about the same as patients with non mutated BRCA gene.

via WordPress http://ift.tt/2rk1j3E

BRCA mutations are not a predictor of higher mortality

Patients with BRCA mutations are 45 -90% more likely to develop breast or ovarian cancer, but mortality is about the same as patients with non mutated BRCA gene.

from WordPress http://ift.tt/2rk1j3E
via IFTTT

Osimertinib for EGFR Non small cell carcinoma

Versus other EGFR inhibitors, osimertinib showed longer progression free survival time

Osimertinib for EGFR Non small cell carcinoma

Versus other EGFR inhibitors, osimertinib showed longer progression free survival time

via WordPress http://ift.tt/2Dx4N5q

Osimertinib for EGFR Non small cell carcinoma

Versus other EGFR inhibitors, osimertinib showed longer progression free survival time

from WordPress http://ift.tt/2Dx4N5q
via IFTTT

Asian Flush from alcohol get higher risk of esophageal cancer

People with a mutant ALD2 gene, are more likely to damage their stem cell DNA. These people flush when drinking alcohol which are more common in Asian population.

from WordPress http://ift.tt/2DpPn2H
via IFTTT

Asian Flush from alcohol get higher risk of esophageal cancer

People with a mutant ALD2 gene, are more likely to damage their stem cell DNA. These people flush when drinking alcohol which are more common in Asian population.

via WordPress http://ift.tt/2DpPn2H

Asian Flush from alcohol get higher risk of esophageal cancer

People with a mutant ALD2 gene, are more likely to damage their stem cell DNA. These people flush when drinking alcohol which are more common in Asian population.

Beta Blockers may improve pancreatic cancer survival

non-selective beta blockers were found to be of benefit in mouse models , when chemotherapy was performed. Mouse who had beta blockers lived longer.

from WordPress http://ift.tt/2AUmHMn
via IFTTT

Beta Blockers may improve pancreatic cancer survival

non-selective beta blockers were found to be of benefit in mouse models , when chemotherapy was performed. Mouse who had beta blockers lived longer.

via WordPress http://ift.tt/2AUmHMn

Beta Blockers may improve pancreatic cancer survival

non-selective beta blockers were found to be of benefit in mouse models , when chemotherapy was performed. Mouse who had beta blockers lived longer.